CD40L/CD40 Regulates Adipokines and Cytokines by H3K4me3 Modification in Epicardial Adipocytes

J Cardiovasc Pharmacol. 2021 Aug 1;78(2):228-234. doi: 10.1097/FJC.0000000000001060.

Abstract

Epicardial adipose tissue (EAT) dysfunction mediates chronic inflammation by regulating inflammation-related adipokines and cytokines, and it further promotes coronary artery disease (CAD) development. CD40L/CD40 is involved in multiple inflammatory pathways that contribute to various pathophysiological processes. However, the function of CD40L/CD40 in the expression and production of adipokines and cytokines in epicardial adipocytes remains unclear. The purpose of the present study was to explore the role and underlying mechanisms of CD40L/CD40 in adipokine and cytokine expression and production. We isolated adipocytes from EAT tissues of CAD and non-CAD patients. We noticed that CD40 was dramatically increased in EAT tissues of CAD patients. Loss-of-function and gain-of-function studies were performed. The results showed that CD40 silencing reduced recombinant CD40 ligand (rCD40L)-induced upregulation of plasminogen activator inhibitor-1, leptin, interleukin-6, and monocyte chemotactic protein-1 messenger RNA levels and secretion. Overexpression of CD40 displayed the opposite results. In addition, rCD40L triggered mixed lineage leukemia protein-1 (MLL1) expression both in messenger RNA and protein levels. CD40 depletion apparently blocked MLL1 expression, whereas gain of function of CD40 resulted in augmentation of MLL1 levels. Interestingly, chromatin immunoprecipitation-quantitative real-time polymerase chain reaction analysis revealed that CD40 elimination dampened histone H3 lysine 4 trimethylation enrichment at plasminogen activator inhibitor-1, leptin, interleukin-6, and monocyte chemotactic protein-1 promoter regions in the presence of rCD40L. The reverse pattern was observed upon ectopic expression of CD40. Most important, MLL1 silencing effectively reversed the promotive effects of CD40 on adipokine and cytokine secretion. Taken together, our findings suggest that CD40L/CD40 regulates adipokine and cytokine expression by H3 lysine 4 trimethylation modification in adipocytes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipocytes / drug effects*
  • Adipocytes / metabolism
  • Adipokines / genetics
  • Adipokines / metabolism*
  • Aged
  • CD40 Antigens / agonists*
  • CD40 Antigens / genetics
  • CD40 Antigens / metabolism
  • CD40 Ligand / pharmacology*
  • Case-Control Studies
  • Cells, Cultured
  • Chemokine CCL2 / genetics
  • Chemokine CCL2 / metabolism
  • Coronary Artery Disease / metabolism*
  • Cytokines / genetics
  • Cytokines / metabolism*
  • Female
  • Histone-Lysine N-Methyltransferase / genetics
  • Histone-Lysine N-Methyltransferase / metabolism
  • Histones / metabolism*
  • Humans
  • Interleukin-6 / genetics
  • Interleukin-6 / metabolism
  • Leptin / genetics
  • Leptin / metabolism
  • Male
  • Methylation
  • Middle Aged
  • Myeloid-Lymphoid Leukemia Protein / genetics
  • Myeloid-Lymphoid Leukemia Protein / metabolism
  • Pericardium / drug effects*
  • Pericardium / metabolism
  • Plasminogen Activator Inhibitor 1 / genetics
  • Plasminogen Activator Inhibitor 1 / metabolism
  • Promoter Regions, Genetic
  • Protein Processing, Post-Translational

Substances

  • Adipokines
  • CCL2 protein, human
  • CD40 Antigens
  • Chemokine CCL2
  • Cytokines
  • Histones
  • IL6 protein, human
  • Interleukin-6
  • KMT2A protein, human
  • LEP protein, human
  • Leptin
  • Plasminogen Activator Inhibitor 1
  • SERPINE1 protein, human
  • CD40 Ligand
  • Myeloid-Lymphoid Leukemia Protein
  • Histone-Lysine N-Methyltransferase